Cita APA (7a ed.)

Kim, C. E., Kleinman, H. K., Sosne, G., Ousler, G. W., Kim, K., Kang, S., & Yang, J. (2018). RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model. Nature Portfolio.

Cita Chicago Style (17a ed.)

Kim, Chae Eun, Hynda K. Kleinman, Gabriel Sosne, George W. Ousler, Kyeongsoon Kim, Sinwook Kang, y Jaewook Yang. RGN-259 (thymosin β4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugs in a Dry Eye Model. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Kim, Chae Eun, et al. RGN-259 (thymosin β4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugs in a Dry Eye Model. Nature Portfolio, 2018.